- Home
- CVAC vs EEX Comparison
CVAC vs EEX Comparison
Compare CVAC & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- EEX
- Stock Information
- Founded
- CVAC 2000
- EEX 2013
- Country
- CVAC Germany
- EEX United States
- Employees
- CVAC N/A
- EEX N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- EEX Advertising
- Sector
- CVAC Health Care
- EEX Consumer Discretionary
- Exchange
- CVAC Nasdaq
- EEX Nasdaq
- Market Cap
- CVAC 764.4M
- EEX 910.8M
- IPO Year
- CVAC 2020
- EEX 2017
- Fundamental
- Price
- CVAC $5.45
- EEX $5.15
- Analyst Decision
- CVAC Hold
- EEX Strong Buy
- Analyst Count
- CVAC 3
- EEX 2
- Target Price
- CVAC $6.83
- EEX $7.90
- AVG Volume (30 Days)
- CVAC 2.2M
- EEX 100.8K
- Earning Date
- CVAC 08-14-2025
- EEX 08-06-2025
- Dividend Yield
- CVAC N/A
- EEX 1.18%
- EPS Growth
- CVAC N/A
- EEX N/A
- EPS
- CVAC 0.87
- EEX 0.02
- Revenue
- CVAC $566,039,775.00
- EEX $413,100,000.00
- Revenue This Year
- CVAC N/A
- EEX $14.85
- Revenue Next Year
- CVAC $24.04
- EEX $6.42
- P/E Ratio
- CVAC $6.31
- EEX $207.04
- Revenue Growth
- CVAC 787.60
- EEX 4.87
- 52 Week Low
- CVAC $2.37
- EEX $3.22
- 52 Week High
- CVAC $5.72
- EEX $6.65
- Technical
- Relative Strength Index (RSI)
- CVAC 65.07
- EEX 65.14
- Support Level
- CVAC $5.36
- EEX $5.11
- Resistance Level
- CVAC $5.45
- EEX $5.30
- Average True Range (ATR)
- CVAC 0.08
- EEX 0.14
- MACD
- CVAC -0.05
- EEX 0.02
- Stochastic Oscillator
- CVAC 58.00
- EEX 85.29
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About EEX Emerald Holding Inc.
Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.